Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies

Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies

Author: Global Tuberculosis Institute at Rutgers The State University of New Jersey, Curry International TB Center, Heartland National Tuberculosis Center, Southeastern National Tuberculosis Center, Mayo Clinic Center for Tuberculosis, Curry International TB Center, SNTC
Publication Date: 2017
Format: Webinar
Language: English

Abstract

This webinar provides an overview of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines and practical tips for implementation. Case studies are also presented.

Publisher:

Global Tuberculosis Institute at Rutgers The State University of New Jersey

Audience(s):

Health Professionals

Topic:

Treatment- TB Disease

Disclaimer: The information on the Find TB Resources Website is made available as a public service. Neither the Centers for Disease Control and Prevention nor the National Prevention Information Network endorses the organizations, Website s, and materials presented. It is the responsibility of the user to evaluate this information prior to use based on individual, community, and organizational needs and standards.